FME Stock Overview
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 5/6 |
Fresenius Medical Care AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €30.76 |
52 Week High | €55.16 |
52 Week Low | €26.48 |
Beta | 0.88 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -49.01% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -55.19% |
Recent News & Updates
Recent updates
Shareholder Returns
FME | BG Healthcare | BG Market | |
---|---|---|---|
7D | 0% | 1.9% | 0.3% |
1Y | -49.0% | -6.2% | 16.0% |
Return vs Industry: FME underperformed the BG Healthcare industry which returned 3.4% over the past year.
Return vs Market: FME underperformed the BG Market which returned 10.8% over the past year.
Price Volatility
FME volatility | |
---|---|
FME Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 5.1% |
Market Average Movement | 4.1% |
10% most volatile stocks in BG Market | 8.2% |
10% least volatile stocks in BG Market | 2.1% |
Stable Share Price: FME has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FME's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 128,044 | Helen Giza | www.freseniusmedicalcare.com |
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.
Fresenius Medical Care AG Fundamentals Summary
FME fundamental statistics | |
---|---|
Market cap | €11.23b |
Earnings (TTM) | €673.41m |
Revenue (TTM) | €19.40b |
16.7x
P/E Ratio0.6x
P/S RatioIs FME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FME income statement (TTM) | |
---|---|
Revenue | €19.40b |
Cost of Revenue | €14.09b |
Gross Profit | €5.31b |
Other Expenses | €4.64b |
Earnings | €673.41m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
May 09, 2023
Earnings per share (EPS) | 2.30 |
Gross Margin | 27.38% |
Net Profit Margin | 3.47% |
Debt/Equity Ratio | 55.2% |
How did FME perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield49%
Payout RatioDoes FME pay a reliable dividends?
See FME dividend history and benchmarksFresenius Medical Care KGaA dividend dates | |
---|---|
Ex Dividend Date | May 17 2023 |
Dividend Pay Date | May 19 2023 |
Days until Ex dividend | 338 days |
Days until Dividend pay date | 336 days |
Does FME pay a reliable dividends?
See FME dividend history and benchmarks